In an expert view piece, Clare Moloney, clinical strategy director at Atlantis Healthcare, a provider of personalized patient support programs, looks at what ma 12 April 2017
As the life sciences industry seeks to improve customer engagements through personalized multichannel communications.the need for quality customer data is great 4 April 2017
In an expert view piece.Michael Jewell.healthcare partner at Cavendish Corporate Finance.discusses why acquiring exclusive rights will continue to be a key driv 28 March 2017
With proposals being discussed for a replacement of the Affordable Care Act (ACA) – or Obamacare – Kent Holtorf, the medical director for The Holtorf Medical Gr 15 March 2017
In an expert view piece, Dana Shears, eMDI business development director of H&T Presspart and Melissa Manice, chief executive and co-founder of Cohero Health, l 7 March 2017
In an expert view piece, the CPA Global, the intellectual property (IP) management company, asks what role IP management will play in protecting pharmaceutical 28 February 2017
Investing in a corporate giving program can be hugely beneficial.not just for the communities your organization supports.but also your business.As well as givin 21 February 2017
According to Public Health England’s Annual Flu Report.there have been more than three million deaths in the UK since 2006 from flu.In an expert view piece.Nick 15 February 2017
With opioid abuse in the USA now a major crisis and the use of certain non-opioids in combination with these drugs a major potential risk.Thomas W.Frederickson. 8 February 2017
In an expert view piece, Jim Sykes, sector managing director for pharmaceutical and life sciences at global talent acquisition and management firm, Alexander Ma 2 February 2017
Integrated delivery networks (IDNs) are growing in importance for pharmaceutical manufacturers as they now represent the majority of the healthcare spend in the 25 January 2017
In an expert view piece, Dr Oded Ben-Joseph and Dr Shawn Manning, from investment bank Outcome Capital, advise on how life sciences companies can curtail risk b 19 January 2017
In an expert view piece, Todd Feaster, clinical program manager for dementia with leading clinical trial technology and specialty services provider Bracket empl 11 January 2017
An inter partes review (IPR) is usually an unpleasant business for a patent owner, writes Greg DeLassus, a principal at international intellectual property (IP) 4 January 2017
In an expert view piece, Michael Jewell, healthcare partner at Cavendish Corporate Finance, explains why we can expect significant M&A activity in the pharma, h 21 December 2016
Our firm recently opened a London-based European office.As we are passionate about bringing paradigm-shifting technologies to patients.writes Outcome Capital’s 13 December 2016
In an Expert View piece, industry analyst Allied Market Research considers the potential and progress of a growing stream of applied clinical immunology. 8 December 2016
In an expert view piece, Roman Mohanlal, chief medical officer at BeyondSpring Pharmaceuticals, tackles the issue which threatens to undermine the entire drugma 29 November 2016
Hospitals and universities participate in clinical research to advance science and get actively involved with the development of new and innovative treatments, 23 November 2016
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.